NAD+ supports cellular energy production and may improve the efficacy of both weight loss medications and peptide protocols
All medications are HSA/FSA eligible, no insurance required, and available in all 50 states without membership fees
This pathway is being studied for its potential to increase energy expenditure and encourage the body to use stored energy, which may support changes in body weight and metabolism
Poor quality products can contain contaminants, incorrect concentrations, or degraded peptide that is ineffective at best and harmful at worst
Skipping this consideration could increase the risk of compounded side effects such as nausea, vomiting, diarrhea, or hypoglycemia when combined with other diabetes medications
Afamelanotide (sometimes called Melanotan I) is MC1R-preferring and is FDA-approved as Scenesse for a rare skin condition called erythropoietic protoporphyria